These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 8253698

  • 21. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
    Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G.
    Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
    [Abstract] [Full Text] [Related]

  • 22. [Effectiveness, safety and practicality of delayed-release minitablets of valproate in bipolar affective disorders].
    Grunze H, Amann B, Schäfer M, Sterr A, Schaerer L, Wild E, Walden J.
    Fortschr Neurol Psychiatr; 2000 Nov; 68(11):496-502. PubMed ID: 11144934
    [Abstract] [Full Text] [Related]

  • 23. Valproate in the treatment of acute mania. A placebo-controlled study.
    Pope HG, McElroy SL, Keck PE, Hudson JI.
    Arch Gen Psychiatry; 1991 Jan; 48(1):62-8. PubMed ID: 1984763
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [Abstract] [Full Text] [Related]

  • 25. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
    Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC.
    Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
    [Abstract] [Full Text] [Related]

  • 26. [Translation and validation of a French version of the Young Mania Rating Scale (YMRS)].
    Favre S, Aubry JM, Gex-Fabry M, Ragama-Pardos E, McQuillan A, Bertschy G.
    Encephale; 2003 Oct; 29(6):499-505. PubMed ID: 15029084
    [Abstract] [Full Text] [Related]

  • 27. Correlates of antimanic response to valproate.
    McElroy SL, Keck PE, Pope HG, Hudson JI, Morris D.
    Psychopharmacol Bull; 1991 Oct; 27(2):127-33. PubMed ID: 1924658
    [Abstract] [Full Text] [Related]

  • 28. The role of sodium valproate as an anti-manic agent.
    Prasad AJ.
    Pharmatherapeutica; 1984 Oct; 4(1):6-8. PubMed ID: 6438650
    [Abstract] [Full Text] [Related]

  • 29. Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients.
    Hirschfeld RM, Allen MH, McEvoy JP, Keck PE, Russell JM.
    J Clin Psychiatry; 1999 Dec; 60(12):815-8. PubMed ID: 10665626
    [Abstract] [Full Text] [Related]

  • 30. Rapid tryptophan depletion as a treatment for acute mania: a double-blind, pilot-controlled study.
    Applebaum J, Bersudsky Y, Klein E.
    Bipolar Disord; 2007 Dec; 9(8):884-7. PubMed ID: 18076538
    [Abstract] [Full Text] [Related]

  • 31. Rational polypharmacy in the bipolar affective disorders.
    Post RM, Ketter TA, Pazzaglia PJ, Denicoff K, George MS, Callahan A, Leverich G, Frye M.
    Epilepsy Res Suppl; 1996 Dec; 11():153-80. PubMed ID: 9294735
    [Abstract] [Full Text] [Related]

  • 32. Relation of serum valproate concentration to response in mania.
    Bowden CL, Janicak PG, Orsulak P, Swann AC, Davis JM, Calabrese JR, Goodnick P, Small JG, Rush AJ, Kimmel SE, Risch SC, Morris DD.
    Am J Psychiatry; 1996 Jun; 153(6):765-70. PubMed ID: 8633687
    [Abstract] [Full Text] [Related]

  • 33. A pharmacoeconomic model of divalproex vs. lithium in the acute and prophylactic treatment of bipolar I disorder.
    Keck PE, Nabulsi AA, Taylor JL, Henke CJ, Chmiel JJ, Stanton SP, Bennett JA.
    J Clin Psychiatry; 1996 May; 57(5):213-22. PubMed ID: 8626353
    [Abstract] [Full Text] [Related]

  • 34. Risperidone in the treatment of mania.
    Tohen M, Zarate CA, Centorrino F, Hegarty JI, Froeschl M, Zarate SB.
    J Clin Psychiatry; 1996 Jun; 57(6):249-53. PubMed ID: 8666562
    [Abstract] [Full Text] [Related]

  • 35. A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania.
    Bowden CL, Swann AC, Calabrese JR, Rubenfaer LM, Wozniak PJ, Collins MA, Abi-Saab W, Saltarelli M, Depakote ER Mania Study Group.
    J Clin Psychiatry; 2006 Oct; 67(10):1501-10. PubMed ID: 17107240
    [Abstract] [Full Text] [Related]

  • 36. [Valproate in the treatment of bipolar disorder].
    Rzewuska M.
    Psychiatr Pol; 2002 Oct; 36(2):239-57. PubMed ID: 12043042
    [Abstract] [Full Text] [Related]

  • 37. Oral loading of sodium valproate compared to intravenous loading and oral maintenance in acutely manic bipolar patients.
    Ghaleiha A, Haghighi M, Sharifmehr M, Jahangard L, Ahmadpanah M, Bajoghli H, Holsboer-Trachsler E, Brand S.
    Neuropsychobiology; 2014 Oct; 70(1):29-35. PubMed ID: 25171133
    [Abstract] [Full Text] [Related]

  • 38. Dosing strategies and time course of response to antimanic drugs.
    Bowden CL.
    J Clin Psychiatry; 1996 Oct; 57 Suppl 13():4-9; discussion 10-2. PubMed ID: 8970500
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of olanzapine and sodium valproate given alone or as add-on therapy in acute mania. A comparative study.
    Kumar A, Gupta M, Jiloha RC, Tekur U.
    Methods Find Exp Clin Pharmacol; 2010 Jun; 32(5):319-24. PubMed ID: 20664822
    [Abstract] [Full Text] [Related]

  • 40. A pilot study of loading versus titration of valproate in the treatment of acute mania.
    Oluboka OJ, Bird DC, Kutcher S, Kusumakar V.
    Bipolar Disord; 2002 Oct; 4(5):341-5. PubMed ID: 12479668
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.